课题基金 / 基金详情

Toll-like Receptors in the Intestinal Epithelium: Receptors of Survival or Death or Both?

Toll-like Receptors in the Intestinal Epithelium: Receptors of Survival or Death or Both?
肠上皮中的 Toll 样受体:生存或死亡或两者兼而有之的受体?
批准号:
5356696
负责人:
Professorin Dr. Elke Cario
金额:
$0.0万
依托单位国家:
德国
项目类别:
Priority Programmes
财政年份:
2002
资助国家:
德国
项目状态:
已结题
起止时间:
2001-12-31 至 2003-12-31

项目摘要

项目成果

Professorin Dr. Elke Cario的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The intestinal epithelium serves as an essential defensive barrier of the mucosal immune system that forms a bipolar interface between the diverse populations of microbes of the lumen and subjacent immune cells present in the lamina propria. Intestinal epithelial cells (IEC) express Toll-like receptors (TLR) as pattern recognition receptors at their apical pole - poised to recognize microbial "pathogen-associated molecular patterns" (PAMPs) as "non-self" and to rapidly initiate innate immune responses. Lumenal PAMPs play a central role in initiation and perpetuation of inflammatory bowel disease (IBD). Recent studies have demonstrated that intestinal epithelial TLR expression is differentially altered in IBD. However, so far, very little is known, about the complex recognition mechanisms and functional immune consequences of TLRs through which the intestinal epithelium constantly interacts with PAMPs. Parallel activation of intestinal epithelial pro- and anti-apoptosis reflects an essential mechanism of mucosal immune defense which appears to be severely imbalanced in IBD. It remains elusive whether PAMP-induced activation of TLRs may mediate apoptosis in IEC. Thus, the aim of this research project is to characterize the potential checkpoint function of TLRs and interacting signaling cascades under physiological and pathophysiological conditions - distinctly triggering either pro- or anti-apoptosis in IEC in response to specific PAMPs in vitro and in vivo. Long-term goal is to comprehend the pathogenetic role of intestinal epithelial TLR dysregulation in IBD and to develop new therapeutic strategies of modulation of immune dysfunction.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Immune modulatory effects of commensal and probiotic microbiota on multidrug resistance to chemotherapy
TLR2 gets trimmed: a novel mechanism of controlling mucosal homeostasis in the intestine
TLR2 als molekulares Angriffsziel zur Behandlung der intestinalen Mukositis unter zytostatischer Chemotherapie
TLR2 as molecular target for intervention in cancer chemotherapy-induced intestinal mucositis
国内基金
海外基金
BCL3介导前列腺癌Lum stem-like细胞干性维持与内分泌治疗抵抗的机制研究
  • 批准号:
    2026JJ70013
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    汤谷雨
  • 依托单位:
CDC like kinase 2调控巨噬细胞极化影响脓毒症肝损伤
  • 批准号:
    2026JJ81104
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    王剑
  • 依托单位:
桂花类胡萝卜素代谢相关新基因OfMYB-like的功能与机制解析
  • 批准号:
    JCZRYB202501133
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
HmWER-like调控花青素影响绣球‘无尽夏’蓝色萼片形成的机制研究
  • 批准号:
    2025JJ50137
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    彭继庆
  • 依托单位: